The mechanisms are real. The human evidence is thin. Almost nobody buying peptides has fixed the free things first, and that is where the data is overwhelming.
In 1974, Guido Schoenenberger and Marcel Monnier at the University of Bern induced delta sleep electrically in rabbits, drew blood from the cerebral venous system, and isolated a nine amino acid chain from it. Injected into awake rabbits, the chain increased delta sleep. They called it delta sleep-inducing peptide.
Fifty years later DSIP is a TikTok product with a mechanism story and almost no clinical footprint. It has never been approved as a medicine anywhere. That gap between an elegant discovery and a licensed drug is the whole subject of this piece.
Peptides are short chains of amino acids that act as signals. Your body already runs on them. The premise behind injecting them is restoration of a signal that has gone quiet, which is a better premise than sedation. The premise is not the problem.
A peptide named after deep sleep has spent fifty years failing to become a medicine. Your wake time has been free the whole time.
Send this to the peptide bro dropping €300 a month on injections and scrolling his phone until midnight.
- Schoenenberger, G.A. & Monnier, M. (1977). Characterization of a delta-electroencephalogram (-sleep)-inducing peptide. Proceedings of the National Academy of Sciences, 74(3).
- Schneider-Helmert, D. (1986). Clinical evaluation of DSIP. In Sleep Peptides: Basic and Clinical Approaches. Springer.
- Teichman, S.L., Neale, A., Lawrence, B. et al. (2006). Prolonged stimulation of growth hormone and IGF-I secretion by CJC-1295, a long-acting analog of GHRH, in healthy adults. Journal of Clinical Endocrinology & Metabolism, 91(3).
- Phillips, A.J.K., Clerx, W.M., O'Brien, C.S. et al. (2017). Irregular sleep/wake patterns are associated with poorer academic performance and delayed circadian and sleep/wake timing. Scientific Reports, 7.
